MTL Cannabis Corp. has received final approval to list its common shares on the Canadian Securities Exchange (the “CSE”) under the trading symbol “MTLC” and to commence trading at the opening of Monday, August 21, 2023.
“Successfully completing a listing on the CSE is a significant milestone and the last step in the business combination between Canada House Cannabis Group Inc. and Montréal Medical Cannabis Inc. Our team has put forward an incredible effort to get us to this point and we are incredibly excited to continue to integrate the businesses and position the Company as a top performer in the Canadian cannabis industry.” – Michael Perron, CEO of MTL Cannabis.
About MTL Cannabis
MTL Cannabis is the parent company of Montréal Medical Cannabis Inc., a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., with clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.
